Course Description

According to the American Heart Association, cardiac arrhythmias have an estimated prevalence of 14.4 million patients in the United States, and they account for more than 40,000 deaths annually. New developments and advances in the management of cardiac arrhythmias, such as newer anticoagulants, atrial appendage closure devices and cardiac implantable electronic devices, afford benefits to patients who suffer from these conditions. Novel analytical approaches and important clinical trials challenge the practicing physician to implement translation of those discoveries into his clinical practice. The gaps that form between new knowledge and changing paradigms in the practice of medicine can only be filled with effective dissemination of the emerging information.

This one-day program is designed to provide clinicians with a review of selected topics in present-day management of patients with cardiac arrhythmias, emphasizing new advances in the field and incorporating current guidelines and evidence-based principles of practice. The format will incorporate didactic lectures as well as case management studies and panel discussions with experts in the field.

Learning Objectives

  • Compare and contrast risks and benefits of oral anticoagulation therapy versus left atrial appendage (LAA) occlusion for the treatment of atrial fibrillation
  • Evaluate specialized pacemakers, including leadless pacing and His bundle pacing, and identify their role in arrhythmia management
  • Recognize the potential for cybersecurity risks for cardiac implantable electronic devices
  • Compare and contrast the risks and benefits of warfarin versus newer anticoagulants including the use of antidotes, and apply appropriate patient selection criteria for the treatment of patients with atrial fibrillation
  • Assess evidence-based clinical studies defining the importance of optimizing cardiac resynchronization therapy (CRT) for patients with congestive heart failure (CHF)
  • Apply appropriate arrhythmia risk stratification in managing patients with hypertrophic cardiomyopathy and defining the appropriate ICD candidate
  • Recognize patient groups at risk for developing PVC-related cardiomyopathy

Event Program

Friday, September 28, 2018

7:30AM

Registration & Continental Breakfast

7:55AM

Welcome & Introductory Remarks

Edward V. Platia, MD

8:00AM

Top 5 Recent Arrhythmia Publications

Michael S. Goldstein, MD

8:20AM

How to Manage Heart Failure Patients Using Hemodynamic Monitoring

Samer S. Najjar, MD, FACC

8:45AM

Ablation: Pearls and Pitfalls

Zayd A. Eldadah, MD, PhD

9:25AM

Anticoagulation Issues and Bleeding

Athanasios Thomaides, MD

panel discussionAM

Panel Discussion

Moderator: Edward V. Platia, MD
Panelists: Zayd A. Eldadah, MD, PhD; Michael S. Goldstein, MD; Samer S. Najjar, MD, FACC; Manish H. Shah, MD; Athanasios Thomaides, MD

10:05AM

BREAK AND VISIT EXHIBITS

10:30AM

Cybersecurity for Cardiac Implantable Electronic Devices

Dhanunjaya Lakkireddy, MD

10:50AM

Panel Discussion

Moderator: Edward V. Platia, MD
Panelists: Dhanunjaya Lakkireddy, MD

11:00AM

Atrial Appendage Closure

Review: Dhanunjaya Lakkireddy, MD (Guest Speaker)
Live Case: Manish H Shah, MD

12:00PM

Lunch

Atrial Fibrillation: Update on Surgical Management

Christian Shults, MD

Friday, September 28, 2018

1:00PM

Management of PVC-Related Cardiomyopathy

David A. Strouse, MD

1:30PM

Role of Specialized Pacemakers: Leadless Pacing and His Bundle Pacing

Sung W. Lee, MD

1:55PM

Primary Prevention ICDs in Patients with Ejection Fraction Above 35%

Glenn R. Meininger, MD

2:20PM

Cardiac Resynchronization Therapy: It’s All About LV Lead Placement

Seth J. Worley, MD

2:45PM

BREAK

3:00PM

Hypertrophic Cardiomyopathy: Update on Arrhythmic Risk Stratification

Margaret Bell Fischer, MD

3:20PM

Ventricular Tachycardia Originating in Difficult Locations

Sarfraz A. Durrani, MD

3:40PM

How to Use and Interpret Genetic Tests for Arrhythmia Syndromes

Susan M. O’Donoghue, MD

4:00PM

PANEL DISCUSSION

Moderator: Edward V. Platia, MD
Panelists: Sarfraz A. Durrani, MD; Margaret Bell Fischer, MD; Sung W. Lee, MD; Glenn R. Meininger, MD; Susan M. O’Donoghue, MD; David A. Strouse, MD; Seth J. Worley, MD

4:30PM

ADJOURN

REGISTRATION FEE:

$55
Register

Registration for Controversies in Cardiac Arrhythmias 2018

Click the register button to visit our secure website for updated program and registration information. We are unable to accept registrations or cancellations by telephone.


Cancellation Policy

Cancellations made in writing by September 10, 2018 will be subject to a 50% penalty. No refunds will be given after September 10, 2018. Cancellations will not be accepted by telephone. In the unlikely event that the course is canceled, we will refund the registration fee, but are not responsible for any travel costs. Please contact us at info@cica-ep.org or (202) 877-7438 if you have questions or need additional information.

Exhibitors

Innovative Echo Guided Treatment for Structural Heart Diseases is a one-day program designed to provide clinicians with a review of selected topics in present day management of patients with structural diseases, emphasizing new innovation in the field, role of echo in clinical practice and guidance for structural heart interventions, and incorporating current guidelines and evidence-based principles of practice. The course is a one day course which will address new developments and advances in the management of structural heart diseases, such as transcatheter aortic and mitral valve replacement , surgical and transcatheter aortic, mitral and tricuspid valve repair, closure of patent foramen ovale and ASD, and left atrial appendage occlusion afford benefits to patients who suffer from these conditions.

Attendees will have ample opportunity during the course for face-to-face time for discussion with exhibitors and we encourage industry to bring simulators or models to provide attendees with hands–on experience with the latest technology.

 

Faculty

Course Director

Edward V. Platia, MD

Director, Cardiac Rhythm Device Program
MedStar Heart and Vascular Institute
MedStar Washington Hospital Center
Professor of Medicine
Georgetown University School of Medicine
Washington, DC

  • Rafique Ahmed, MD, PhD

    Cardiac Electrophysiologist
    MedStar Good Samaritan Hospital
    MedStar Heart and Vascular Institute
    Baltimore, MD

  • Sarfraz A. Durrani, MD

    Director, Physician Outreach and Complex Arrhythmia
    Management Program
    MedStar Washington Hospital Center
    MedStar Heart & Vascular Institute at Fairfax
    Assistant Professor of Clinical Medicine, Cardiology
    Georgetown University School of Medicine
    Fairfax, VA

  • Zayd A. Eldadah, MD, PhD

    Director, Section of Cardiac Electrophysiology
    MedStar Washington Hospital Center
    MedStar Georgetown University Hospital
    MedStar Heart & Vascular Institute
    Washington, DC

  • Margaret Bell Fischer, MD

    Director, Congenital and Structural Arrhythmia Program
    Section of Cardiac Electrophysiology
    MedStar Washington Hospital Center
    MedStar Georgetown University Hospital
    Washington, DC
    MedStar Heart & Vascular Institute at Fairfax
    Fairfax, VA

  • Michael S. Goldstein, MD

    Cardiac Electrophysiologist
    MedStar Washington Hospital Center
    MedStar Heart & Vascular Institute
    Washington, DC

  • Dhanunjaya Lakkireddy, MD (Guest Speaker)

    Executive Medical Director,
    Kansas City Heart Rhythm Institute
    HCA Midwest Health
    Overland Park, KS

  • Sung W. Lee, MD

    Director, Cardiac Electrophysiology Lab
    MedStar Southern Maryland Hospital Center
    MedStar Heart & Vascular Institute
    Clinton, MD

  • Glenn R. Meininger, MD

    Medical Director, Cardiac Electrophysiology Services
    Baltimore Region
    MedStar Heart & Vascular Institute
    Clinical Associate Professor
    University of Maryland
    Baltimore, MD

  • Samer S. Najjar, MD

    Medical Director, Advanced Heart Failure Program,
    Heart Transplantation and Mechanical Circulatory Support
    MedStar Washington Hospital Center
    MedStar Heart & Vascular Institute
    Washington, DC

  • Susan M. O’Donoghue, MD

    Director, Cardiogenetics Services
    MedStar Washington Hospital Center
    MedStar Heart & Vascular Institute
    Washington, DC

  • David J. Schamp, MD

    Chief, Electrophysiology
    MedStar Union Memorial Hospital
    MedStar Heart & Vascular Institute
    Baltimore, MD

  • Manish H. Shah, MD

    Director, Cardiac Electrophysiology Fellowship Training Program
    MedStar Washington Hospital Center
    MedStar Heart & Vascular Institute
    Washington, DC

  • Christian Shults, MD

    Cardiac Surgeon
    MedStar Washington Hospital Center
    MedStar Heart & Vascular Institute
    Washington, DC

  • David A. Strouse, MD

    Director, Outreach for Device and Complex Ablations
    MedStar Georgetown University Hospital
    Washington, DC
    MedStar Heart & Vascular Institute at Fairfax
    Fairfax, VA

  • Athanasios Thomaides, MD

    Cardiac Electrophysiologist
    MedStar Washington Hospital Center
    MedStar Heart & Vascular Institute
    Washington, DC

  • Allison C. Warren, MD

    Cardiac Electrophysiologist
    MedStar Washington Hospital Center
    MedStar Heart & Vascular Institute
    Washington, DC

  • Seth J. Worley, MD

    Senior Consultant, Cardiac Rhythm Device Management
    MedStar Washington Hospital Center
    MedStar Heart & Vascular Institute
    Washington, DC

Venue

THE COSMOS CLUB

2121 Massachusetts Avenue, NW,
Washington, DC